
The flexible dosing schedule has been approved for patients with skin, lung and cervical cancer

Results show trevogrumab prevents lean mass and muscle loss during GLP-1 weight loss

Rinvoq is the first and only systemic medication approved in the EU for NSV

Globally, around 150 to 200 out of every million people have myasthenia gravis

Cases of measles have been rising in Europe since 2023

Regeneron will pay Parabilis $125m upfront, with up to $2.2bn in potential milestone payments and royalties

Around 1.4 million people in the UK are diagnosed with COPD, with two million thought to be undiagnosed

Phase 3 trial results showed the drug significantly improved disease-free survival

Marketing authorisation follows positive late-stage trial results

The drug is already approved in the EU across three other multiple myeloma indications

The drug is already approved in the EU to treat relapsed or refractory cases of the blood cancer

The early precursor of active multiple myeloma accounts for around 15% of all new multiple myeloma cases